Concepedia

Publication | Open Access

Enzalutamide in Metastatic Prostate Cancer before Chemotherapy

DOIFull Paper Access

3K

Citations

22

References

2014

Year

Tomasz M. Beer, Andrew J. Armstrong, Dana E. Rathkopf, Yohann Loriot, Cora N. Sternberg, Celestia S. Higano, Peter Iversen, Suman Bhattacharya, Joan Carles, Simon Chowdhury,
New England Journal of Medicine

Abstract

Enzalutamide significantly decreased the risk of radiographic progression and death and delayed the initiation of chemotherapy in men with metastatic prostate cancer. (Funded by Medivation and Astellas Pharma; PREVAIL ClinicalTrials.gov number, NCT01212991.).

References

YearCitations

Page 1